Sarcomatoid transformation in renal cell carcinoma, so called sacromatoid RCC (sRCC), is associated with an aggressive behavior and a poor prognosis. Current therapeutic approaches are largely ineffective. Recent studies looking into the genomic and molecular characterization of sRCCs have provided insights into the biology and pathogenesis of this entity. These advances in molecular signatures may help development of effective treatment strategies. We herein present a review of recent developments in the pathology, biology, and treatment modalities in sRCC.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.urolonc.2017.12.012 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!